Tranexamic acid: the importance of correct use and individualized risk-benefit analysis

被引：0
|
作者：
Pekrul, Isabell [1 ]
Schachtner, Thomas [2 ]
Zwissler, Bernhard [3 ]
Moehnle, Patrick [1 ]
机构：
[1] Univ Munchen LMU, Klin Anaesthesiol, Abt Transfus Med Zelltherapeutika & Hamostaseol, Marchioninistr 15, D-81377 Munich, Germany
[2] Schon Klin Munchen Harlaching, Anasthesie & Intens Med, Munich, Germany
[3] Univ Munchen LMU, Klin Anaesthesiol, Munich, Germany
来源：
ANAESTHESIST | 2021年 / 70卷 / 07期
关键词：
TOTAL HIP; FIBRINOLYSIS;
D O I：
10.1007/s00101-021-00990-z
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：616 / 617
页数：2
相关论文
共 50 条
  • [1] Tranexamsäure: der Stellenwert des korrekten Einsatzes und einer individualisierten Risiko-Nutzen-AbwägungTranexamic acid: the importance of correct use and individualized risk-benefit analysis
    Isabell Pekrul
    Thomas Schachtner
    Bernhard Zwißler
    Patrick Möhnle
    Der Anaesthesist, 2021, 70 (7) : 616 - 617
  • [2] The Risk-Benefit Profile of Aprotinin Versus Tranexamic Acid in Cardiac Surgery
    Karkouti, Keyvan
    Wijeysundera, Duminda N.
    Yau, Terrence M.
    McCluskey, Stuart A.
    Tait, Gordon
    Beattie, W. Scott
    ANESTHESIA AND ANALGESIA, 2010, 110 (01): : 21 - 29
  • [3] Risk-benefit analysis of emergency vaccine use
    Gregory Lewis
    Michael Bonsall
    Scientific Reports, 12
  • [4] Risk-benefit analysis of emergency vaccine use
    Lewis, Gregory
    Bonsall, Michael
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [5] Risk-benefit analysis
    Mossman, KL
    HEALTH PHYSICS, 2002, 82 (05): : 750 - 750
  • [6] Risk-benefit analysis
    Wilson, R.
    Crouch, E.A.C.
    Physics Today, 2002, 55 (10)
  • [7] RISK-BENEFIT ANALYSIS
    ZENCEY, M
    ATLANTIC, 1979, 243 (04): : 37 - 37
  • [8] DEVELOPMENT OF A RISK-BENEFIT ANALYSIS TOOL FOR USE OF IVACAFTOR
    Garrod, A.
    Weiner, D.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 282 - 283
  • [9] Risk-benefit analysis of micronutrients
    Renwick, AG
    Flynn, A
    Fletcher, RJ
    Müller, DJG
    Tuijtelaars, S
    Verhagen, H
    FOOD AND CHEMICAL TOXICOLOGY, 2004, 42 (12) : 1903 - 1922
  • [10] THE FALLACIES OF RISK-BENEFIT ANALYSIS
    SAMUELS, SW
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1979, 329 (OCT) : 267 - 273
12345